Evaluation and medical management of benign prostatic hyperplasia

28Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Benign prostatic hyperplasla (BPH) is common among aging men. Untreated BPH may lead to complications including urinary tract infection, acute urinary retention, arod obstructive nephropathy. Diagnosing BPH can be challenging because lower urinary tract symptoms are found in conditions other than BPH, and prostate size correlates poorly with symptoms of obstruction. Nonetheless, a careful medical history and physical examination, along with prudent use of diagnostic tests, can yield an accurate diagnosis. We review the evaluation of men with suspected BPH and indications for referral to a urologist for invasive therapy. We also review supporting evidence and treatment considerations for saw palmetto and the 2 major classes of prescription medications, α1-adrenergic antagonists and 5α-reductase inhibitors. © 2005 Mayo Foundation for Medical Education and Research.

Cite

CITATION STYLE

APA

Beckman, T. J., & Mynderse, L. A. (2005). Evaluation and medical management of benign prostatic hyperplasia. In Mayo Clinic Proceedings (Vol. 80, pp. 1356–1362). Elsevier Ltd. https://doi.org/10.4065/80.10.1356

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free